Intrahepatic cholestasis most often occurs in diseases involving hepatocellular damage, leakage, or swelling, such as infections (e.g., bacterial cholangiohepatitis, toxoplasmosis, FIP, or other diseases causing inflammation), infiltrative diseases (e.g., lymphoma), metabolic diseases (e.g., hepatic lipidosis), or diseases causing disruption of architecture (e.g., cirrhosis or severe polycystic disease)
Dose reduction of these medications may be necessary according to American Diabetes Association guidelines
Both hormone changes from menopause and mid-life stressors contribute to poor sleep. Poor quality sleep can also increase ghrelin
Home Home page AOD 9604 SOLD OUT AOD 9604Starting at $55.00 Amount Choose an option5 MG How Many
JiangRBabyakMBrummettBHauserEShahSBeckerRet alBrain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort
Exploiting metabolic vulnerabilities of cancer with precision and accuracy